Sign In


Breaking News

ACS CAN applauds FDA intent to curb cigarette smoking through reduced nicotine levels

Food and Drug Administration (FDA) Commissioner Scott Gottlieb announced on March 15 an Advanced Notice of Proposed Rulemaking (ANPRM) aimed at reducing nicotine levels in cigarettes to levels that no longer cause or sustain addiction.  

A statement from ACS CAN president Chris Hansen follows: 

“We applaud Commissioner Gottlieb for taking deliberate action to address the leading cause of preventable disease and death in this country – an addiction that is still killing more than 480,000 Americans every year. Such an action is a game changer that could transform the marketplace. 

“If based on thorough science and understanding, the reduction of nicotine to a non-addictive level in combustible tobacco products could enable the millions of tobacco users who want to quit to do so far more easily. In the case of new smokers—most of whom are children and adolescents—it could prevent addiction from the outset.

“Research into the science of nicotine addiction and consumer behavior highlights that the cigarette industry has long engineered and manipulated its products to enhance addictiveness by more effectively targeting the brains and central nervous systems of consumers. 

ACS CAN strongly advocates that maximum levels of nicotine be set for all combustible tobacco products, not just cigarettes. Such an action can prevent tobacco industry manipulation of keeping smokers addicted to the deadliest products – those that burn tobacco.

“To achieve its public health goal, the FDA must issue an evidence-based final rule in the most expedient way possible and have enforcement authorities in place to ensure compliance and prevent product manipulation by the tobacco industry. The American Cancer Society Cancer Action Network (ACS CAN) will respond strongly to the proposal in support of an evidence-based product standard that will reduce morbidity and mortality from tobacco use. 

“This important action by Commissioner Gottlieb should be part of a comprehensive tobacco control strategy undertaken across the entire agency. The FDA must use the full force of its authority in a scientific and transparent manner to address not only nicotine levels in tobacco products, but flavoring in products, review of new products and modified risk claims, and innovative opportunities to promote cessation medications. By taking a comprehensive approach to tobacco control, we can save lives, keep kids from starting lifelong, deadly addictions and end the scourge of tobacco on the American people in our lifetime.”

  • A recap of our live colorectal cancer awareness event - watch the replay!

    Did you watch our March 8 Colorectal Cancer Screening Coast to Coast: Driving toward Prevention event, broadcast live from Smashbox Studios in Los Angeles? If not, a replay of this informative awareness-raising event emceed by Desiree Berenguer-Carton can be viewed on the Society's Facebook page. Make sure to like it and share it! You also can watch it on YouTube.

    The full show was shared 129 times on ACS Facebook page, including by partners with broad reach, such as Katie Couric, Stand Up to Cancer, National Alliance for Hispanic Health, the American College of Gastroenterology, Telemundo star Chiquibaby (who has 600,000 followers), and many others.

    We're now in 2018 – the year we aimed to get 80% of U.S. adults 50 and over screened for colorectal cancer. Did we make it? We actually don't know for sure because of a lag in the data. We do know that we reached 67.3% in 2016, with more than a 150 health systems, clinics, and localities actually reaching 80%, and hundreds more seeing substantial rate increases. That 67.3% figure is new data from CDC.

    Rich Wender, MD, our chief cancer control officer, said between 2014 and 2016, an additional 3 million people got screened, and that follows a three-year plateau reported by CDC, when screening rates did not budge. That is great news!

    As Rich said, "no skeptics allowed. We are doing this, we are making a difference, and screening rates are going up around the country." And, of course, we will continue to act with urgency through 2018 – and beyond. (For answers to questions you might have about what happens after 2018, read this.)

    The core message of the event was clear: colorectal cancer is the second leading cause of cancer death in U.S. when men and women are combed, but it does not need to be! Getting screened and having precancerous polyps removed can prevent this cancer. And, there is a test for everyone. 80% by 2018 is not a colonoscopy campaign. There are simple take-home tests that people can use, if that's what they are most comfortable doing. The best test, we always say, is the one that gets done.

    Two other facts we learned on this program: 

    • There are now more than 1 million survivors of colorectal cancer in the U.S.
    • 1600 organizations have signed the 80% pledge, and they are not stopping their efforts after 2018 

    The event was a collaborative partnership among the American Cancer Society, the National Colorectal Cancer Roundtable, and Fight Colorectal Cancer, in partnership with the Mayo Clinic, Exact Sciences, UPS, and others.

    Here is a list of some of the guests interviewed on the show: 

    • Anjee Davis, president, Fight Colorectal Cancer
    • Country singer Craig Campbell, whose dad died from colon cancer at age 36. Craig performed a song he co-wrote with Rose Hausmann, who died in 2016 after a 12-year battle with stage IV colorectal cancer. It is called "Stronger Than That," and serves as an anthem for colorectal cancer survivors.
    • Lisa Richardson, MD, MPH, director of CDC's Division of Cancer Prevention and Control, who said the biggest challenge is getting people in their early 50's screening. Less than half of people between ages 50 and 55 have been screened, she said. 
    • Stephanie "Chiquibaby" Himonidis, host of Telemundo 52's Acceso Total program, which provides viewers with lots of health information.
    • Teri Griege, a stage IV colon cancer survivor who completed the Ironman World Championship in Kona, Hawaii while still undergoing chemotherapy. Screening is better than treatment, she said, adding: "Don't die of embarrassment."
    • Samuel Pace, MD, a longtime gastroenterologist in Tupelo, Mississippi and two-time colorectal cancer survivor. He is a 2018 80% by 2018 National Achievement Awards honoree in the Survivor/Physician Champion category. "The best medicine" for survivors, he said, is to become an advocate, and educate others on the importance of getting screened.
    • Robyn Sunday-Allen, CEO of the Oklahoma City Indian Clinic, this year's 80% by 2018 National Achievement Awards grand prize winner. The clinic serves 20,000 Native Americans and its colorectal cancer screening rate jumped from 14% in 2007 to 64% in 2016. Tactics included systematizing patient and provider reminders, improving tracking in the electronic health record, offering incentives for completing screening at health fairs, and providing navigation to patients in need of follow up care. Read more about all of the awardees here.
    • Thomas Lopez, who urged people not to do what he did – wait nine months to go to the doctor after finding blood in his stool. People in the Latino community often go to the doctor too late, he said. "I prayed to God every night to let me live long enough to see my son graduate from high school." 

    Shout outs from Luke Perry and Katie Couric

    Actor Luke Perry was busy filming Riverdale, the TV show he appears in, but called in on his smart phone.  Journalist Katie Couric, who underwent a colonoscopy on-air in March 2000, two years after her 42-year-old husband died of colon cancer, also sent her regrets for not being there in a pre-recorded video. She said this month she is taking a 50-year-old mystery date to his first colonoscopy. Look for that on social media!

    This event, which was national, is just one of many colorectal cancer awareness events going on across the U.S. Find other events around the country and submit your local events to be added to the map. 

    PHOTOS: Pictured in the top photo are all of ACS staff involved in the event, including staff from Global Headquarters and West Region. The smaller image shows some of the 150 audience members who filled the studio.

  • ACS CAN's Monthly Advocacy Update


    Short-Term Funding Bill Increases Cancer Research Funding, Protects Access to Health Care Services

    On Feb. 9, Congress passed and the President signed a short-term extension to the FY18 spending bill which includes several ACS CAN priorities. The bipartisan deal increases investment in medical research funding over the next two years and lifts budget caps for FY18 and FY19 budgets, enabling appropriators to work to finalize FY18 spending bills. The bill also allows for an increase of at least $1 billion for the National Institutes of Health (NIH) for FY18 and FY19 each recognizing NIH as a critical national priority and acknowledging the importance of reliable funding growth for medical research at NIH.

    The bill also protects access to care for millions of low-income Americans. It also includes two years of funding for Federally Qualified Health Centers (FQHCs) and an additional four years of funding for the Children's Health Insurance Program (CHIP) beyond the six-year extension that Congress approved in January. Extending funding for FQHCs and CHIP will make it possible for millions of low-income adults and children, including many cancer patients, to receive critical health care services.

    While the legislation addresses a number of critical federal programs that are instrumental in making progress against cancer, ACS CAN is disappointed that it cuts the Prevention and Public Health Fund by $1.35 billion as an offset. Funding for effective prevention programs is essential to reducing death and suffering from cancer.

    Administration Budget Threatens to Undo Advances in Cancer Fight

    Yesterday, the administration released its FY19 budget proposal which includes a minimum $1 billion cut for medical research at NIH, significantly less than the amount House and Senate committees have approved for FY 18 funding levels. The administration's budget also reduces funding and eliminates important cancer screening and prevention programs at CDC, eliminates subsidies for purchasing health insurance through the exchanges, and transforms Medicaid funding into a per capita cap or block grant structure. In our press release, ACS CAN detailed the considerable risks to cancer research, prevention, early detection and treatment if the administration's budget is implemented.

    Through advocacy, we will urge Congress to reject these proposed cuts and to build on the broad bipartisan consensus around support for medical research including cancer research at the NIH by appropriating at least $2 billion per year for FY18 and FY19.

    ACS CAN will also press lawmakers to maintain funding for cancer prevention and screening programs at the Centers for Disease Control (CDC) and for important tobacco cessation programs through the Office of Smoking and Health (OSH).


    ACS CAN Joins Many Patient Advocates to Oppose Proposed Right to Try Legislation

    On Feb. 6, ACS CAN, together with nearly 40 other patient organizations sent a letter to U.S. House Leadership today opposing proposed Right to Try legislation being considered in the House. The letter notes, "The Right to Try bills currently under consideration in the House do not effectuate policy changes that would afford our patients greater access to promising investigational therapies. Instead, these bills would likely do more harm than good."

    The groups note that when access to a therapy is denied to a patient, it is generally the company that denies the request, rather than the Food and Drug Administration (FDA), for reasons such as a determination that the benefits do not outweigh the risks or lack of sufficient product to offer outside of clinical trials.

    The letter urges leadership to instead consider legislation that, "would improve the ability of patients to genuinely and safely access unapproved therapies."

    ACS CAN Submits Comments to the Centers for Medicare and Medicaid Services

    On Jan. 16, ACS CAN filed comments in response to the Centers for Medicare and Medicaid Services' (CMS) proposed rule implementing changes to the Medicare Part C and Part D programs. ACS CAN commented on a number of proposed issues, including:

    • Implementation of the Comprehensive Addiction and Recovery Act (CARA)CMS proposed to implement a number of policies as required under the CARA, which requires Medicare Part D plans to limit access to opioids for beneficiaries deemed at-risk for misuse or abuse. ACS CAN raises a number of questions related to how this policy will be implemented for cancer patients and asks CMS to issue clarifications.  
    • Medicare Advantage (MA) Plan Flexibility: CMS proposed to allow MA plans additional flexibility to reduce cost-sharing for certain benefits for its enrollees. ACS CAN is generally supportive of the proposal, but cautioned that CMS should engage in careful monitoring to ensure that plans are not using the flexibility to increase costs to beneficiaries.
    • Limitations on the Special Enrollment Period (SEP) for Low-income Subsidy (LIS) BeneficiariesCMS proposed to limit the ability for LIS beneficiaries to switch Part D plans mid-year. ACS CAN urged CMS not to adopt the policy at this time because these beneficiaries may need to switch plans if their current plan undergoes a mid-year formulary change.
    • MA Quality Rating SystemCMS proposed to require that quality reporting be done at the plan rather than organizational level. ACS CAN supported this provision because it would more accurately reflect the quality of care provided to beneficiaries. CMS also proposed new policies regarding the adoption of new quality measures. ACS CAN is concerned that the proposed policy would result in a lag time between when the quality measures are first proposed and when they are actually implemented by CMS.
    • Request for Information on Manufacturer Rebates and Pharmacy Price Concessions: Included in the proposed rule is a request for information (RFI) on requiring Part D plans to include a minimum percentage of manufacturer rebates and pharmacy price concessions be included in the negotiated price at the point of sale. CMS does not propose specific regulations, but rather is using the proposed rule as an opportunity to solicit comment that will be used for future rulemaking. ACS CAN is generally supportive of the policies outlined in the RFI.

    Activities in the States

    ACS CAN Comments Help Proposed Rule Avoid Negative Impact on Medical Research 

    In the latter stages of his administration, New Jersey's governor, Chris Christie, prioritized policies addressing the opioid epidemic in a variety of ways, including a proposed rule intended to provide additional oversight of the financial relationship between prescribers and pharmaceutical manufacturers. Of specific concern to ACS CAN was a proposed cap on payments to physicians for their services which would have had an unintended effect on cancer drug development. The cap would have limited the ability of physicians to enroll patients in clinical trials and stall commercial drug development in the state.

    ACS CAN submitted comments on the rule to the Division of Consumer Affairs, explaining that while the aim of the proposed rule was laudable, it could inadvertently result in the limitation of appropriate payments and ultimately cause a significant negative impact on cancer research and clinical trials in the state. The final rule was adopted on Jan. 16, and due in part to ACS CAN's engagement on the issue, included amendments ensuring that the compensation cap specifically excludes research and clinical trials.


  • Sunday, Feb. 4, is World Cancer Day

    ​Patriots and Eagles fans won't be the only ones celebrating on Super Bowl Sunday. That day also happens to be World Cancer Day, a global opportunity to raise the profile of cancer in people's minds and in the world's media.

    Many cancer-fighting organizations, including the American Cancer Society, will use this day to get more people talking about a disease that causes about 1 in 7 deaths worldwide, and is rapidly becoming a global pandemic. Currently, 8.8 million people die from cancer worldwide every year, 4 million of which are between the ages of 30 and 69.

    Our World Cancer Day activities include:

    • A special World Cancer Day video that will be shared via CEO Gary Reedy's social media accounts, available here.
    • A new graphic on the home page of, along with a special landing page that will go live at approximately 8 p.m. ET tonight, Feb. 2. 
    • A guest blog post by Ambassador Sally Cowal, our senior vice president for global cancer control, available on Research America's website.

    How you can help

    Sign up now to help support the World Cancer Day's Thunderclap campaign. If you do that, a World Cancer Day message will automatically be posted on your selected social media pages at 6 a.m. ET on Feb. 4. Your choices are Facebook, Twitter, and Tumblr. You may add a personal message, if you wish, but it is not necessary. Sign up now!

    Kickoff is not until 6:30 p.m., so you have plenty of time to promote the importance of prevention, early detection, and the great work of the American Cancer Society. 

    Social media 

    Of course, our social media channels will be promoting World Cancer Day, too, along with The Defender, a digital health tool people can use to get free personalized tips to reduce their cancer risk. In the spirit of the old adage "the best defense is a good offense,'" people can enter information about their height, weight, physical activity, and more, and then get recommendations for actions to take. The Defender was developed by ACS and funded by the National Football League. Visit the site at

    More about World Cancer Day

    Kicking off the observance on Feb. 3, will be the 8th annual illumination of the Empire State Building tower in the World Cancer Day colors of orange and blue.

    World Cancer Day is an initiative of the Union for International Cancer Control (UICC) , which has a membership base of more than 1,000 organizations in more than 160 countries. It represents the world’s major cancer societies, ministries of health, and patient groups, and includes influential policy makers, researchers, and experts in cancer prevention and control. Sally Cowal, senior VP, Global Cancer Control, is a member of its Board of Directors.


    Work Cancer Day materials

    How the American Cancer Society is working globally to fight cancer

  • ACS CAN: Cancer patients, recent survivors should be exempt from possible Medicaid work requirements

    Today, Jan. 11, the Centers for Medicare and Medicaid Services (CMS) issued guidance allowing states to require “able-bodied” adults to work, participate in job training, or volunteer in order to receive Medicaid health benefits. As part of the guidance, CMS exempts children, pregnant women, the disabled, and those who are deemed, “medically frail,” however the guidance does not clearly define who would be considered medically frail.

    A statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN) follows:

    “Today’s guidance could mean a significant change to one of America’s most essential safety-net programs. Medicaid serves as a vital lifeline that provides health care coverage to more than 2.3 million low-income Americans with a history of cancer.

    “Many cancer patients in active treatment are often unable to work or require significant accommodations to their work schedules due to that treatment. It is unclear from the guidance what standards states would use to define “medically frail.” The unintended consequence may be disadvantaging patients with cancer and serious illnesses. Research suggests between 40 and 85 percent of cancer patients stop working while receiving cancer treatment, with absences ranging from 45 days to six months. Additionally, evidence shows that patients who have recently completed treatment may need additional time to recover and transition back into the workplace.

    “We strongly urge CMS to require states exempt people with serious, complex medical conditions, particularly cancer patients and recent survivors from any work requirements. ACS CAN welcomes any opportunity to assist in this process.” 

  • Proposed health plan rule likely to leave patients with insufficient coverage at higher costs

    As directed by the President’s executive order, the Department of Labor issued proposed rules on Jan. 4 governing the expansion of association health plans (AHP).

    A statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN) follows:

    “While the proposed rule released today allows for the sale of additional insurance products, past experience has shown that these products would weaken patient protections and potentially divide the individual insurance market.  

    “The proposed rule would allow AHPs to offer insurance coverage that would likely have lower premiums because these products would cover fewer benefits, and be exempt from many of the patient protections provided under current law. This will likely split the health insurance market because these products would be attractive to younger and healthier individuals. As a result, those with serious health conditions like cancer would be left paying ever-increasing premiums for comprehensive coverage.

    “The rule proposed today will almost certainly result in more people facing financial distress when an unexpected health crisis happens and they discover their AHP coverage is inadequate.

    “Cancer patients and survivors need access to high quality affordable insurance that provides comprehensive coverage. ACS CAN will raise concerns with policymakers through the public comment period to protect patients from the risk and consequences of a divided and potentially problematic insurance market.”

  • Top 10 cancer news stories of 2017

    ACS staff who write for work hard every day to bring the public the latest news and information about cancer topics. They monitor scientific journal articles, government health and cancer reports, and studies from our own American Cancer Society researchers to deliver the news people need about ways to lower their risk from cancer, and ways to cope with the disease.

    These writers and editors have chosen the 10 most significant stories that made headlines on this year. They are:

    Just a little bit of walking may help you live longer
    Even a little bit of exercise can go a long way toward improving your health. A study led by American Cancer Society researchers found that older people benefitted from walking at an average pace, even if they walked for less than two hours a week. Read more.

    U.S. tobacco companies forced to tell the truth about cigarettes
    Major U.S. tobacco companies – the makers of most cigarettes sold in the U.S. – have begun running court-ordered ads that admit they purposefully designed their products to be addictive, even though they knew their health effects were deadly. Read more.

    Birth control pills are still linked to cancer risk
    Newer forms of birth control contain less hormone drugs than older forms, and it was hoped they’d also cause less of an increase in breast cancer risk. But a study in the New England Journal of Medicine shows the risk is still about the same. Even so, our expert says this is not cause for alarm. Read more.

    Rates of colon and rectal cancer are increasing among young adults
    The rate at which new colon and rectal cancer cases are diagnosed is dropping among older adults, but increasing among younger adults – those under age 50. We explore the reasons behind the increase, and what can be done about it. Read more.

    Few people are getting recommended screening for lung cancer
    Lung cancer screening could save thousands of lives each year, if everyone eligible got the tests. But American Cancer Society researchers have found that very few people actually do. Lung cancer screening is recommended for people at high risk – mostly current and former smokers. Read more.

    Younger kids can get 2 HPV vaccination shots instead of three
    The human papillomavirus (HPV) vaccine series is safe and effective, and it can prevent several types of cancer. Now boys and girls who get the vaccine between ages 9 and 14 can get two doses instead of three, making it that much easier. The recommended age to start the HPV vaccine is 11 or 12 to get the best protection. Read more.

    Observation may be a good choice for prostate cancer treatment
    A study led by the Minneapolis VA Health Care System shows men who have surgery for early-stage prostate cancer live no longer than those who choose observation, which means watching the cancer carefully over time to make sure it’s not getting worse. What’s more, surgery often left men with side effects that needed treatment. Read more.

    Many women missing out on genetic counseling for breast cancer treatment decisions
    Genetic testing can give women with breast cancer crucial information in deciding what type of surgery or other treatment to get. But a study in the Journal of the American Medical Association shows that only about half of women who could benefit from genetic testing are receiving it. Read more.

    Costs continue to increase for cancer drugs in the U.S.
    Cancer treatment is expensive – so expensive that people sometimes go without filling prescriptions, just to save money. A study in the Journal of Clinical Oncology looked at the costs of cancer drugs over time and found steep increases, even when generic versions went on the market. Read more.

    Work life has its challenges for cancer survivors
    Working as a cancer survivor is a desire for some and a necessity for others. Some people feel well enough to work during treatment, while others may need a little time off – or a lot. We offer tips on ways to avoid pitfalls and make the transition easier. Read more.

  • ACS CAN releases first-of-its-kind survey assessing the impact of paid medical leave on cancer patients, survivors, and caregivers

    The American Cancer Society Cancer Action Network (ACS CAN) on Dec. 14 released a first-of-its-kind survey assessing the impact of paid medical leave on cancer patients, survivors and, caregivers. The survey of more than 800 people affected by cancer revealed those with paid leave overwhelmingly said it had a positive effect on their physical and financial health.

    Among patients and survivors who said they used paid medical leave, 80 percent said it helped them complete their treatment; 70 percent said it helped them manage side effects or symptoms; and 64 percent said paid leave helped them afford their treatments.

    “Having access to paid leave is important when thinking about the entirety of cancer patients’ needs,” said Chris Hansen, president of ACS CAN. “Cancer is an incredibly intense, time consuming and costly disease. Being able to take time off to receive and complete necessary treatment, or to care for a loved one undergoing treatment, without sacrificing one’s career, or overall economic well-being makes a difference.”

    About half of patients and survivors surveyed said they had access to paid medical/family leave, a benefit that allows for extended time off from work beyond standard “sick days.” Only 4 in 10 (43 percent) of caregivers said they had access to paid leave; among those who did, nearly 60 percent said it improved their ability to go to a loved one’s doctor or treatment appointments and improved their overall ability to care for their loved one. Forty percent said paid leave had a positive impact on their own health during their caregiving.

    According to the survey, those working for large employers and earning higher salaries were most likely to have access to paid leave. For instance, 66 percent of patients and survivors who worked for companies with 1,000 or more employees reported having paid medical leave versus just 34 percent of those who work for employers with fewer than 100 workers.

    “The issue is that those who work for small employers or have lower wage jobs are more likely to need that leave and have fewer resources available to compensate if they don’t have access to it,” said Hansen.

    Of those surveyed who used any sort of leave, 81 percent of patients and 95 percent of survivors and caregivers said they returned to work with their same employer after finishing their leave, pointing to the potential employer benefit in providing such leave.

    Public Opinion Strategies conducted the survey from September 18-29. Read the full results

  • ACS CAN joins other leading patient advocacy groups to urge Senate to reject health bill

    On Sept. 25, ACS CAN volunteers joined patients, consumers, and leading patient advocacy groups at a press conference in Washington, D.C. to voice their concerns about health care legislation that was under consideration in the U.S. Senate.

    A day later, Senate leaders announced that they will not vote on the latest health care legislation this week. Saturday, Sept. 30, is the deadline for the Senate to be able pass a repeal bill with just 51 votes.

    During the Protect Patients NOW event and throughout the day, opponents called on senators to reject the Graham-Cassidy health bill and to preserve quality health care access and coverage for millions of Americans. Read the post-event press release here.

    ACS CAN volunteer Steve Taylor (pictured above), a three-time cancer survivor from Alaska, relies on expensive monthly injections to keep his genetic form of pancreatic cancer in check. Each injection costs more than $10,000, but without it his tumors would grow and lead to his early death. Proposed insurance changes in the pending Graham-Cassidy legislation could allow insurance plans in certain states to cap or opt out of treatments like prescription drugs, leaving Taylor with few, if any, options for his care.

    “With my health history any possible caps on coverage would pose a serious threat to my physical and financial health,” Taylor said. “I can’t afford $10,000 a month, but what option would I have? I just hope Senator Murkowski and her colleagues consider the real consequences of this bill and vote no.”

    The press conference, which took place shortly before the only scheduled hearing on the legislation, was organized by a number of patient and public interest groups, including the American Cancer Society Cancer Action Network (ACS CAN), American Diabetes Association, American Heart Association, American Lung Association, Consumers Union, and the National Multiple Sclerosis Society. 

    The groups oppose many of the Graham-Cassidy health bill's key provisions, including giving states the option to waive the requirement that plans cover essential health benefits such as certain cancer treatments or care, allowing insurers to potentially charge people more based on their health status, and drastically cutting critical Medicaid funding. 

    ACS CAN expert one of six panelists invited to testify before the Senate Finance Committee

    Dick Woodruff, ACS CAN senior VP of federal advocacy, was among a panel of six that testified about proposed health care changes the Graham-Cassidy bill would bring. He told the senators it could leave millions of cancer patients and survivors without access to adequate, affordable health insurance coverage. You can watch his testimony here. It runs from 1:24:48 to 1:30:26. 

    Dick called for bipartisan cooperation on meaningful ways to improve the current health care system, and stated that ACS CAN stands ready to work with the Committee and all members of Congress to develop a proposal that makes health care adequate and affordable for all Americans.

    The six-member panel the committee heard from also included co-author of the bill, U.S. Sen. Bill Cassidy, MD, (R-LA); Rick Santorum, former U.S. senator from Pennsylvania; Dennis G. Smith, senior advisor for Medicaid and Health Care Reform, Arkansas Department of Human Services; Teresa Miller, acting secretary, Department of Human Services, Commonwealth of Pennsylvania; and Cindy Mann, former deputy administrator and director of the Center for Medicaid and CHIP Services, Centers for Medicare & Medicaid Services, U.S. Dept. of Health and Human Services.

    Read more about the Sept. 25 events here and visit

    TOP PHOTO: Steve Taylor, an ACS CAN volunteer from Alaska, shared his personal story at today’s press conference. 

back to top